The department continues to expand its clinical trials program, focusing on innovative research for dermatological conditions, including those without FDA-approved treatments such as hidradenitis suppurativa and prurigo nodularis. Ongoing and upcoming studies target conditions like psoriasis, atopic dermatitis, and non-invasive treatments for skin cancers.
The program’s growth is bolstered by the addition of a dermatology research fellow and a new clinical trials coordinator. Collaborations with pharmaceutical companies leverage our faculty’s expertise and access to niche patient populations through 12 specialty clinics. These efforts advance clinical research opportunities, offering high-quality data for industry partners and fostering engagement in groundbreaking studies.
Points of Contact
Clinical trials research opportunities: Dr. Brian Simmons & our research coordinator or Staci Shaw
Examples of Clinical Trials, Conditions, Products, and Faculty
| Study Description | Skin Condition | Population | Investigational Product | Faculty |
|---|---|---|---|---|
| Microbiome | All skin conditions | Pediatric & Adults | N/A | Barton |
| Smart Practice | Metal Allergens | Adults | N/A | Simmons |
| USCLC Registry | Cutaneous Lymphoma | Adults | N/A | Carter |
| BI PG | Ulcerative Pyoderma Gangrenosum | Adults | Spesolimab | Simmons |
| Alpine | Lichen Planopilaris | Adults | Brepocitinib | Simmons |
| Beacon | Cutaneous Sarcoidosis | Adults | Brepocitinib | Simmons |
| Takeda | Psoriasis | Adults | Oral TAK-279-3001 | Khanna |
| Switch Up | Atopic eczema | Adults | Dupilumab vs Upadacitinib | Simmons |
| AbbVie M16-047 | Atopic Dermatitis | Adults | Upadacitinib | Simmons |
| AbbVie M20-465 | Hidradenitis Suppurativa | ≥12 y.o | Lutikizumab | Fragoso |
